T3 Pharmaceuticals was acquired by Boehringer Ingelheim for $508m
22 November 2023
22 November 2023
Total investments received (USD): N/A
Round value (USD): 508m
Round investors:
Boehringer Ingelheim Venture Fund
Company: T3 Pharmaceuticals
Industry:
Health services
Pharma
Related deals
Alys Pharmaceuticals raised $100 million seed with Medicxi
Investments
04 February 2024
Belgium
Netherlands
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain